522 related articles for article (PubMed ID: 16831267)
21. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
22. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
23. [Impact of AFP promoter on the expressions of GFP in tumor cells].
Mao CQ; Huang CZ; Yang SD; Zhao M; Fan YX; Xu F; Du F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):495-8. PubMed ID: 12905870
[TBL] [Abstract][Full Text] [Related]
24. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.
Kanai F; Lan KH; Shiratori Y; Tanaka T; Ohashi M; Okudaira T; Yoshida Y; Wakimoto H; Hamada H; Nakabayashi H; Tamaoki T; Omata M
Cancer Res; 1997 Feb; 57(3):461-5. PubMed ID: 9012474
[TBL] [Abstract][Full Text] [Related]
25. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
[TBL] [Abstract][Full Text] [Related]
26. [Adenovirus p16(INK4A) gene therapy for laryngeal squamous cell carcinoma].
Liu SX; Tang SQ; Liang CY
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):35-8. PubMed ID: 12778765
[TBL] [Abstract][Full Text] [Related]
27. [Construction, packaging and titration of recombinant adeno-associated virus vectors contaning antitumor genes].
Zhang Y; Leng X; Peng J; He X; Lu J; Weng S; Wang S; Du J
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):564-7. PubMed ID: 12133507
[TBL] [Abstract][Full Text] [Related]
28. [Recombinant adenovirus-mediated overexpression of TIMP-1 effectively suppresses hepatocellular carcinoma cell line HepG2 in vitro and in vivo].
Xia D; Xu L; Fu H; Qi XL; Quan Y; Yan LN
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):813-7. PubMed ID: 18396636
[TBL] [Abstract][Full Text] [Related]
29. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
Ma XJ; Huang R; Kuang AR
Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
[TBL] [Abstract][Full Text] [Related]
30. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
31. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
Dai M; Liu J; Chen DE; Rao Y; Tang ZJ; Ho WZ; Dong CY
Cancer Gene Ther; 2012 Feb; 19(2):77-83. PubMed ID: 21959967
[TBL] [Abstract][Full Text] [Related]
32. [Immunization with dendritic cells infected with human AFP adenovirus vector effectively elicits immunity against mouse hepatocellular carcinomas].
Tan XH; Zhu Q; Liu C; Liu XL; Shao XT; Wei B
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):13-6. PubMed ID: 16737612
[TBL] [Abstract][Full Text] [Related]
33. In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.
Kim KI; Park JH; Lee YJ; Lee TS; Park JJ; Song I; Nahm SS; Cheon GJ; Lim SM; Chung JK; Kang JH
J Gene Med; 2012 Aug; 14(8):513-20. PubMed ID: 22761128
[TBL] [Abstract][Full Text] [Related]
34. [The induced apoptosis of recombinant adenovirus carrying melittin gene for hepatocellular carcinoma cell].
Li B; Ling CQ; Zhang C; Gu W; Li SX; Huang XQ; Zhang YN; Yu CQ
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):453-5. PubMed ID: 15329201
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
[TBL] [Abstract][Full Text] [Related]
36. [Impact of p16INK4A and p15INK4B on human hepatocellular carcinoma cell proliferation and apoptosis].
Qin Y; Liu JY; Li B; Peng WZ; Fu MD; Sun ZL; Sun ZF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):132-7. PubMed ID: 15079795
[TBL] [Abstract][Full Text] [Related]
37. [Construction of recombinant adenovirus carrying human IFNgamma gene by in vitro ligation and its expression].
Xue G; Li Y; Liu RY; Tian FZ; Huang WL
Ai Zheng; 2006 Jun; 25(6):771-4. PubMed ID: 16764779
[TBL] [Abstract][Full Text] [Related]
38. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
Willhauck MJ; Sharif Samani BR; Klutz K; Cengic N; Wolf I; Mohr L; Geissler M; Senekowitsch-Schmidtke R; Göke B; Morris JC; Spitzweg C
Gene Ther; 2008 Feb; 15(3):214-23. PubMed ID: 17989705
[TBL] [Abstract][Full Text] [Related]
39. Gene therapy by membrane-expressed superantigen for alpha-fetoprotein-producing hepatocellular carcinoma.
Si S; Sun Y; Li Z; Ge W; Zhang X; Hu P; Huang Y; Chen G; Song H; Huang Y; Ma B; Li X; Sui Y
Gene Ther; 2006 Nov; 13(22):1603-10. PubMed ID: 16855617
[TBL] [Abstract][Full Text] [Related]
40. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
